within Pharmacolibrary.Drugs.ATC.C;

model C08CA15
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.06,
    Cl             = 0.00010833333333333333,
    adminDuration  = 600,
    adminMass      = 8 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0066,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.004833333333333333,
    Tlag           = 19.8,            
    Vdp             = 0.0040999999999999995,
    k12             = 6.1,
    k21             = 6.1
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C08CA15</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Benidipine is a dihydropyridine calcium channel blocker used for the treatment of hypertension and angina pectoris. It is an approved oral antihypertensive agent in several Asian countries, including Japan, but is not approved in the United States or Europe.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult Japanese volunteers after a single oral dose.</p><h4>References</h4><ol><li><p>Sunwoo, YE, et al., &amp; Shin, JG (2019). Effect of rifampin on enantioselective disposition and anti-hypertensive effect of benidipine. <i>British journal of clinical pharmacology</i> 85(4) 737–745. DOI:<a href=\"https://doi.org/10.1111/bcp.13848\">10.1111/bcp.13848</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/30589098/\">https://pubmed.ncbi.nlm.nih.gov/30589098</a></p></li><li><p>Buddhadev, SS, et al., &amp; Pasha, I (2024). Quality by design aided self-nano emulsifying drug delivery systems development for the oral delivery of Benidipine: Improvement of biopharmaceutical performance. <i>Drug delivery</i> 31(1) 2288801–None. DOI:<a href=\"https://doi.org/10.1080/10717544.2023.2288801\">10.1080/10717544.2023.2288801</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/38073402/\">https://pubmed.ncbi.nlm.nih.gov/38073402</a></p></li><li><p>Kang, WK, et al., &amp; Kwon, KI (2005). Assessing the bioequivalence of 4- and 8-mg benidipine tablets in healthy volunteers after a single oral dose. <i>Journal of clinical pharmacy and therapeutics</i> 30(1) 85–90. DOI:<a href=\"https://doi.org/10.1111/j.1365-2710.2004.00614.x\">10.1111/j.1365-2710.2004.00614.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/15659008/\">https://pubmed.ncbi.nlm.nih.gov/15659008</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C08CA15;
